SCHEMBL6713334

SCHEMBL6713334

CN(C)c1ccc2onc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 11/20 0.45
FAAH O00519 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
PDK1 Q15118 1/20 0.35
GRM5 P41594 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
F10 P00742 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713150 0.89 HIF1A (0.43) HIF1AMEN1KMT2ANPC1LMNA
SCHEMBL6711746 0.87 HIF1A (0.41) HIF1ATP53MAPTALDH1A1POLB
SCHEMBL6710266 0.86 HIF1A (0.44) HIF1AMEN1KMT2ANPC1RAB9A
SCHEMBL6708718 0.86 HIF1A (0.42) HIF1AGRM5MEN1KMT2ANPC1
SCHEMBL6709172 0.86 HIF1A (0.42) HIF1AGRM5MEN1KMT2ANPC1
SCHEMBL6710157 0.86 ALDH1A1 (0.40) HIF1AMEN1KMT2ANPC1LMNA
SCHEMBL6710375 0.85 HIF1A (0.57) HIF1A
SCHEMBL6708056 0.85 HIF1A (0.46) HIF1AGRM5MEN1KMT2AKDM4E
SCHEMBL6709879 0.85 HIF1A (0.48) HIF1AFAAHHSP90AA1HSP90AB1PDK1
SCHEMBL6707764 0.84 HIF1A (0.41) HIF1AGRM5MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885FAAH 884/4885HSP90AA1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.